Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 3

TABLE OF CONTENTS Volume 47, Issue 3 (March 2012) In this issue Editorial Reviews Special Report Original Articles Letters to the Editor Also new AOP Advertisement The CliniMACS® Cell Separation System, based on MACS® Technology, enables the operator to perform clinical-scale magnetic enrichment of target cells or depletion of unwanted cells. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement IBMS BoneKEy Webinars Sign up now for the next webinar LIVE expert led presentations on hot topics in the bone field presented as a PowerPoint lecture, followed by a discussion panel with world-renowned bone scientists and clinicians. Sign up for the next webinar and visit video presentations and summaries of previous webinars.   Editorial Top Making the diagnosis of gastrointestinal GVHD: is evaluation of the ileum necessary? W A Ross and A M Alousi Bone Marrow Transplant 2012 47: 321-322; 10.1038/bmt.2011.157 Full Text Reviews Top Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? M E Bernardo, A M Cometa and F Locatelli Bone Marrow Transplant 2012 47: 323-329; advance online publication, May 9, 2011; 10.1038/bmt.2011.102 Abstract | Full Text Hematopoietic cell transplantation for Waldenström macroglobulinemia V Bachanova and L J Burns Bone Marrow Transplant 2012 47: 330-336; advance online publication, May 16, 2011; 10.1038/bmt.2011.105 Abstract | Full Text Special Report Top Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation N S Majhail, J D Rizzo, S J Lee, M Aljurf, Y Atsuta, C Bonfim, L J Burns, N Chaudhri, S Davies, S Okamoto, A Seber, G Socie, J Szer, M T Van Lint, J R Wingard and A Tichelli for the Center for International Blood and Marrow Transplant Research, American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Asia-Pacific Blood and Marrow Transplantation Group, Bone Marrow Transplant Society of Australia and New Zealand, East Mediterranean Blood and Marrow Transplantation Group and Sociedade Brasileira de Transplante de Medula Ossea Bone Marrow Transplant 2012 47: 337-341; 10.1038/bmt.2012.5 Abstract | Full Text Original Articles Top STEM CELL PROCUREMENT Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo A Olivieri, M Marchetti, R Lemoli, C Tarella, A Iacone, F Lanza, A Rambaldi and A Bosi on behalf of the Italian Group for Stem Cell Transplantation (GITMO) Bone Marrow Transplant 2012 47: 342-351; advance online publication, May 30, 2011; 10.1038/bmt.2011.82 Abstract | Full Text PEDIATRIC TRANSPLANTS Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients M Mynarek, J Tolar, M H Albert, M L Escolar, J J Boelens, M J Cowan, N Finnegan, A Glomstein, D A Jacobsohn, J S Kühl, H Yabe, J Kurtzberg, D Malm, P J Orchard, C Klein, T Lücke and K-W Sykora Bone Marrow Transplant 2012 47: 352-359; advance online publication, May 9, 2011; 10.1038/bmt.2011.99 Abstract | Full Text IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD C M Jol-van der Zijde, R G M Bredius, A M Jansen-Hoogendijk, S Raaijmakers, R M Egeler, A C Lankester and M J D van Tol Bone Marrow Transplant 2012 47: 360-368; advance online publication, September 5, 2011; 10.1038/bmt.2011.166 Abstract | Full Text ALLOGRAFTING Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning S Yoshihara, K Ikegame, K Taniguchi, K Kaida, E H Kim, J Nakata, R Kato, T Inoue, T Fujioka, H Tamaki, M Okada, T Soma and H Ogawa Bone Marrow Transplant 2012 47: 369-373; advance online publication, April 11, 2011; 10.1038/bmt.2011.84 Abstract | Full Text Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome D-Y Kim, J-H Lee, Y-H Park, J-H Lee, S-D Kim, Y Choi, S-B Lee, K-H Lee, S Y Ahn, Y-S Lee, M Seol, Y-A Kang, M Jeon, A R Jung, Y-J Lee and K-H Lee Bone Marrow Transplant 2012 47: 374-379; advance online publication, April 11, 2011; 10.1038/bmt.2011.86 Abstract | Full Text The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries J Abelsson, M Merup, G Birgegård, O WeisBjerrum, L Brinch, M Brune, P Johansson, M Kauppila, S Lenhoff, M Liljeholm, C Malm, K Remes, L Vindelöv and B Andréasson for the Nordic MPD Study Group Bone Marrow Transplant 2012 47: 380-386; advance online publication, May 9, 2011; 10.1038/bmt.2011.91 Abstract | Full Text Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT N Imahashi, Y Inamoto, M Ito, D Koyama, T Goto, K Onodera, A Seto, K Watanabe, M Imahashi, S Nishiwaki, S Tsukamoto, T Yasuda, Y Ozawa and K Miyamura Bone Marrow Transplant 2012 47: 387-394; advance online publication, April 18, 2011; 10.1038/bmt.2011.95 Abstract | Full Text AUTOGRAFTING Single-agent high-dose melphalan followed by auto-SCT for relapsed and refractory Hodgkin lymphoma in children and adolescents G M T Guilcher, F A Rizzuti, V A Lewis and D A Stewart Bone Marrow Transplant 2012 47: 395-398; advance online publication, May 9, 2011; 10.1038/bmt.2011.97 Abstract | Full Text POST-TRANSPLANT EVENTS High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency H Olteanu, A M Harrington, B George, P N Hari, C Bredeson and S H Kroft Bone Marrow Transplant 2012 47: 399-403; advance online publication, April 11, 2011; 10.1038/bmt.2011.83 Abstract | Full Text Salivary secretion in children after fractionated or single-dose TBI K Garming Legert, M Remberger, O Ringdèn, A Heimdahl and G Dahllöf Bone Marrow Transplant 2012 47: 404-410; advance online publication, May 9, 2011; 10.1038/bmt.2011.96 Abstract | Full Text GRAFT-VERSUS-TUMOR EFFECTS CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia Y Metaxas, H Bertz, A Spyridonidis, M Spyroupoulou-Vlachou, C Porzelius and J Finke Bone Marrow Transplant 2012 47: 411-415; advance online publication, May 9, 2011; 10.1038/bmt.2011.101 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Mucosal microvilli in dry eye patients with chronic GVHD Y Tatematsu, Y Ogawa, S Shimmura, M Dogru, S Yaguchi, T Nagai, K Yamazaki, K Kameyama, S Okamoto, Y Kawakami and K Tsubota Bone Marrow Transplant 2012 47: 416-425; advance online publication, May 16, 2011; 10.1038/bmt.2011.89 Abstract | Full Text M-CSF attenuates severity of chronic GVHD after unrelated BMT F Kimura, K Sato, H Akiyama, H Sao, S Okamoto, N Kobayashi, M Hara, K Kawa and K Motoyoshi for The Japan Marrow Donor Program Bone Marrow Transplant 2012 47: 426-429; advance online publication, April 18, 2011; 10.1038/bmt.2011.90 Abstract | Full Text Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients W Kreisel, M Dahlberg, H Bertz, J Harder, K Potthoff, P Deibert, A Schmitt-Graeff and J Finke Bone Marrow Transplant 2012 47: 430-438; advance online publication, June 27, 2011; 10.1038/bmt.2011.137 Abstract | Full Text PRE-CLINICAL STUDIES Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc− mouse model J Gregoire-Gauthier, L Durrieu, A Duval, F Fontaine, M M Dieng, M Bourgey, N Patey-Mariaud de Serre, I Louis and E Haddad Bone Marrow Transplant 2012 47: 439-450; advance online publication, May 16, 2011; 10.1038/bmt.2011.93 Abstract | Full Text Letters to the Editor Top Impact of parainfluenza virus type 3 infection on engraftment after hematopoietic SCT M Toupin, A Hamadah, S Madore, R Padmore and D S Allan Bone Marrow Transplant 2012 47: 451-452; advance online publication, April 11, 2011; 10.1038/bmt.2011.85 Full Text High-dose melphalan followed by auto-SCT has favorable safety and efficacy in selected patients with light chain deposition disease and light and heavy chain deposition disease D Telio, J Shepherd, D Forrest, L Zypchen, M Barnett, T Nevill and K W Song Bone Marrow Transplant 2012 47: 453-455; advance online publication, April 18, 2011; 10.1038/bmt.2011.87 Full Text Post-autologous hematopoietic SCT engraftment syndrome:a single center experience R Lopes da Silva, F Costa, G Ferreira and A B de Sousa Bone Marrow Transplant 2012 47: 456-457; advance online publication, April 18, 2011; 10.1038/bmt.2011.92 Full Text Rituximab treatment may disturb the normal pattern of lymphopoiesis after cord blood SCT P Barba, I Garcia-Cadenas, J Nomdedéu, R Martino, L Gallur and D Valcárcel Bone Marrow Transplant 2012 47: 458-460; advance online publication, May 9, 2011; 10.1038/bmt.2011.98 Full Text Epithelial cells in PBSC grafts: source of donor-type epithelial cells after allogeneic transplantation? F M Khan, S Sy, P Louie, M Smith, J Chernos, J A Russell and J Storek Bone Marrow Transplant 2012 47: 461-462; advance online publication, May 23, 2011; 10.1038/bmt.2011.100 Full Text Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT D Nakamura, M Yoshimitsu, H Kawada, H Inoue, T Kuroki, T Kaieda, S Fujino, H Hamada, S Suzuki, K Matsushita, K Uozumi and N Arima Bone Marrow Transplant 2012 47: 463-464; advance online publication, May 9, 2011; 10.1038/bmt.2011.103 Full Text Candida kefyr fungal enteritis following autologous BMT S Direkze, M Mansour, M Rodriguez-Justo, C Kibbler, V Gant and K S Peggs Bone Marrow Transplant 2012 47: 465-466; advance online publication, May 30, 2011; 10.1038/bmt.2011.112 Full Text Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT A M O Leal, M C Oliveira, C E B Couri, D A Moraes, A-BPL Stracieri, F Pieroni, R D A Soares, G N Barros, B P Simões, M C Foss and J C Voltarelli Bone Marrow Transplant 2012 47: 467-468; advance online publication, May 30, 2011; 10.1038/bmt.2011.113 Full Text Advertisement Visit the Medical Genomics Series Web Focus on Cardiovascular Disease The Journal of Human Genetics is proud to present the Medical Genomics Series Web Focus on Cardiovascular Disease - a collection of the latest original and review articles on cardiovascular diseases, such as myocardial infarction, stroke, atherosclerosis, aortic aneurysm, heart failure and hypertension. Access the Web Focus today!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.